Latest filing published 26 Aug 2025 for Sutro Biopharma, INC., €5,950.
Insider track record
No signal scores available.
Barbara Leyman: trading record in brief
Barbara Leyman is a declared insider of Sutro Biopharma, Inc., with filings sourced from SEC (Form 4). The record holds 2 filings, all for trades on 8 July 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 26 August 2025, reports a share grant of €5,950 in Sutro Biopharma, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Barbara Leyman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,944 shares@ US$0.78100.0% of flowCommon StockSEC:0001415889-25-023084:1
- 25,000 shares0Common StockSEC:0001415889-25-023084:0
2 of 2 declarations
